RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 66 filers reported holding RECRO PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,000 | -77.8% | 663 | -78.7% | 0.00% | – |
| Q4 2020 | $9,000 | +350.0% | 3,119 | +201.4% | 0.00% | – |
| Q3 2020 | $2,000 | -71.4% | 1,035 | -38.5% | 0.00% | – |
| Q2 2020 | $7,000 | +600.0% | 1,683 | +1110.8% | 0.00% | – |
| Q1 2020 | $1,000 | -99.8% | 139 | -99.5% | 0.00% | – |
| Q4 2019 | $556,000 | +2547.6% | 30,300 | +1548.5% | 0.00% | – |
| Q3 2019 | $21,000 | +16.7% | 1,838 | +2.4% | 0.00% | – |
| Q2 2019 | $18,000 | +1700.0% | 1,795 | +1173.0% | 0.00% | – |
| Q1 2019 | $1,000 | -66.7% | 141 | -63.4% | 0.00% | – |
| Q4 2018 | $3,000 | +200.0% | 385 | +215.6% | 0.00% | – |
| Q3 2018 | $1,000 | -94.1% | 122 | -96.4% | 0.00% | – |
| Q2 2018 | $17,000 | -64.6% | 3,359 | -22.4% | 0.00% | – |
| Q1 2018 | $48,000 | +14.3% | 4,328 | -5.2% | 0.00% | – |
| Q4 2017 | $42,000 | +7.7% | 4,564 | +5.5% | 0.00% | – |
| Q3 2017 | $39,000 | +387.5% | 4,328 | +296.0% | 0.00% | – |
| Q2 2017 | $8,000 | – | 1,093 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 872,494 | $6,195,000 | 3.64% |
| Newtyn Management, LLC | 1,600,000 | $11,360,000 | 2.22% |
| Broadfin Capital, LLC | 2,048,025 | $14,541,000 | 1.91% |
| Balter Liquid Alternatives, LLC | 92,167 | $654,000 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 515,414 | $3,660,000 | 0.29% |
| JT Stratford LLC | 45,367 | $322,000 | 0.21% |
| Opus Point Partners Management, LLC | 11,353 | $81,000 | 0.18% |
| Alyeska Investment Group, L.P. | 964,000 | $6,844,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 500,625 | $3,554,000 | 0.09% |
| Monarch Partners Asset Management LLC | 55,857 | $397,000 | 0.06% |